Literature DB >> 21180599

Anti-tumor necrosis factor therapy and influenza: keeping it in perspective.

Matt Shale1, Markus Czub, Gilaad G Kaplan, Remo Panaccione, Subrata Ghosh.   

Abstract

The association of opportunistic infections in the context of anti-tumor necrosis factor (TNF) antibody therapies have attracted widespread attention. The recent H1N1 influenza pandemic brought this into sharp focus with numerous patient queries and physician anxieties. The following short review gives a scientific perspective to this issue including the role of vaccination.

Entities:  

Keywords:  anti-tumor necrosis factor antibody; inflammatory bowel disease; influenza; vaccine

Year:  2010        PMID： 21180599      PMCID： PMC3002575          DOI： 10.1177/1756283X10366368

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN： 1756-283X            Impact factor:   4.409


  30 in total

1.  Factors influencing uptake of influenza vaccination in patients with rheumatoid arthritis.

Authors:  M J Bridges; D Coady; C A Kelly; J Hamilton; C Heycock
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

2.  Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients.

Authors:  M C Kapetanovic; T Saxne; J-A Nilsson; P Geborek
Journal:  Rheumatology (Oxford)       Date:  2006-11-18       Impact factor: 7.580

3.  Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses.

Authors:  Gil Y Melmed; Andrew F Ippoliti; Konstantinos A Papadakis; Tram T Tran; Jaime L Birt; Susie K Lee; Robert W Frenck; Stephan R Targan; Eric A Vasiliauskas
Journal:  Am J Gastroenterol       Date:  2006-06-30       Impact factor: 10.864

4.  Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab.

Authors:  Jeffrey L Kaine; Alan J Kivitz; Charles Birbara; Allison Y Luo
Journal:  J Rheumatol       Date:  2007-02       Impact factor: 4.666

5.  Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells.

Authors:  Sang Heui Seo; Robert G Webster
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.

Authors:  Stephen B Hanauer; William J Sandborn; Paul Rutgeerts; Richard N Fedorak; Milan Lukas; Donald MacIntosh; Remo Panaccione; Douglas Wolf; Paul Pollack
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

7.  Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007.

Authors:  Anthony E Fiore; David K Shay; Penina Haber; John K Iskander; Timothy M Uyeki; Gina Mootrey; Joseph S Bresee; Nancy J Cox
Journal:  MMWR Recomm Rep       Date:  2007-07-13

8.  Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients.

Authors:  Yukiko Komano; Masayoshi Harigai; Ryuji Koike; Haruhito Sugiyama; Jun Ogawa; Kazuyoshi Saito; Naoya Sekiguchi; Masayuki Inoo; Ikuko Onishi; Hiroyuki Ohashi; Fujio Amamoto; Masayuki Miyata; Hideo Ohtsubo; Kazuko Hiramatsu; Masahiro Iwamoto; Seiji Minota; Naoki Matsuoka; Goichi Kageyama; Kazuyoshi Imaizumi; Hitoshi Tokuda; Yasumi Okochi; Koichiro Kudo; Yoshiya Tanaka; Tsutomu Takeuchi; Nobuyuki Miyasaka
Journal:  Arthritis Rheum       Date:  2009-03-15

9.  Lethal H5N1 influenza viruses escape host anti-viral cytokine responses.

Authors:  Sang Heui Seo; Erich Hoffmann; Robert G Webster
Journal:  Nat Med       Date:  2002-08-26       Impact factor: 53.440

10.  Pandemic influenza and pregnant women.

Authors:  Sonja A Rasmussen; Denise J Jamieson; Joseph S Bresee
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883
View more
  11 in total

1.  TNF deficiency dysregulates inflammatory cytokine production, leading to lung pathology and death during respiratory poxvirus infection.

Authors:  Ma Junaliah Tuazon Kels; Esther Ng; Zahrah Al Rumaih; Pratikshya Pandey; Sigrid R Ruuls; Heinrich Korner; Timothy P Newsome; Geeta Chaudhri; Gunasegaran Karupiah
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-22       Impact factor: 11.205

2.  Coadministration of Hedera helix L. Extract Enabled Mice to Overcome Insufficient Protection against Influenza A/PR/8 Virus Infection under Suboptimal Treatment with Oseltamivir.

Authors:  Eun-Hye Hong; Jae-Hyoung Song; Aeri Shim; Bo-Ra Lee; Bo-Eun Kwon; Hyuk-Hwan Song; Yeon-Jeong Kim; Sun-Young Chang; Hyeon Gun Jeong; Jong Geal Kim; Sang-Uk Seo; HyunPyo Kim; YongSoo Kwon; Hyun-Jeong Ko
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

3.  Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs.

Authors:  Jehun Song; Seongmin Kang; Seung Won Choi; Kwang Won Seo; Sunggun Lee; Min Wook So; Doo-Ho Lim
Journal:  Rheumatol Int       Date:  2020-04-20       Impact factor: 2.631

4.  Prioritizing genes responsible for host resistance to influenza using network approaches.

Authors:  Suying Bao; Xueya Zhou; Liangcai Zhang; Jie Zhou; Kelvin Kai-Wang To; Binbin Wang; Liqiu Wang; Xuegong Zhang; You-Qiang Song
Journal:  BMC Genomics       Date:  2013-11-21       Impact factor: 3.969

5.  COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.

Authors:  Claudio Conforti; Roberta Giuffrida; Caterina Dianzani; Nicola Di Meo; Iris Zalaudek
Journal:  Dermatol Ther       Date:  2020-03-22       Impact factor: 2.851

Review 6.  Treating Influenza Infection, From Now and Into the Future.

Authors:  Sophia Davidson
Journal:  Front Immunol       Date:  2018-09-10       Impact factor: 7.561

Review 7.  COVID-19 and dermatology: a comprehensive guide for dermatologists.

Authors:  D H Fahmy; H S El-Amawy; M A El-Samongy; A A Fouda; S H Soliman; A El-Kady; F Farnetani; A Conti; A Zoeir; A Eissa; R Eissa; S Puliatti; M C Sighinolfi; B Rocco; G Pellacani
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-10       Impact factor: 9.228

Review 8.  COVID-19 infection and rheumatoid arthritis: Faraway, so close!

Authors:  Ennio Giulio Favalli; Francesca Ingegnoli; Orazio De Lucia; Gilberto Cincinelli; Rolando Cimaz; Roberto Caporali
Journal:  Autoimmun Rev       Date:  2020-03-20       Impact factor: 9.754

Review 9.  Divergent Mast Cell Responses Modulate Antiviral Immunity During Influenza Virus Infection.

Authors:  Ashleigh R Murphy-Schafer; Silke Paust
Journal:  Front Cell Infect Microbiol       Date:  2021-02-19       Impact factor: 5.293

10.  COVID-19 and immunosuppressants: An opinion pool of practicing dermatologists of India.

Authors:  Arunima Ray; Ipsita Debata; Ishan Agrawal; Maitreyee Panda
Journal:  Dermatol Ther       Date:  2020-08-14       Impact factor: 3.858
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.